- Torrent Pharmaceuticals Q1 revenue rose 54.8% to Rs 4,921 crore year-on-year
- Ebitda increased 61.2% to Rs 1,664 crore, with margin improving to 33.8%
- Net profit grew 3.3% to Rs 566 crore, impacted by a one-time Rs 21 crore loss
Torrent Pharmaceuticals reported a strong operational performance in the first quarter, with revenue and Ebitda posting robust double-digit growth. However, net profit growth remained muted due to a one-time loss incurred during the quarter. On a consolidated basis, the drugmaker reported a net profit of Rs 566 crore for the quarter, up 3.3% from Rs 548 crore in the corresponding period last year.
Revenue from operations surged 54.8% year-on-year to Rs 4,921 crore from Rs 3,178 crore, reflecting strong growth across the business.
Operating performance remained healthy, with Ebitda rising 61.2% to Rs 1,664 crore from Rs 1,032 crore a year earlier. The company's Ebitda margin improved to 33.8% from 32.5% in the year-ago quarter, indicating better operating efficiency despite a challenging environment.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Torrent Pharma Q1 Result Highlights (Cons, YoY)
- Net Profit rises 3.3% at Rs 566 crore versus Rs 548 crore.
- Revenue rises 54.8% at Rs 4,921 crore versus Rs 3,178 crore.
- Ebitda rises 61.2% at Rs 1,664 crore versus Rs 1,032 crore.
- Margin at 33.8% versus 32.5%.
- Includes one-time loss of Rs 21 crore in Q1.
Torrent Pharma said the quarter's earnings included a one-time loss of Rs 21 crore, which weighed on the bottom line and limited the growth in net profit despite the sharp improvement in operating performance.
Torrent Pharma Share Price Today
The results were announced after market close. Gland Pharma shares closed 1.05% lower at Rs 2,517 per share on Thursday. The shares have risen 6.07% in one week and 1.08% in one month. The shares are up 47.05% year-to-date and 22.39% in the last one year.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
